Protease inhibitor–associated angiolipomatosis - 05/09/11
Abstract |
Treatment with protease inhibitors in some persons infected with HIV-1 is associated with a syndrome of lipodystrophy manifesting as peripheral lipoatrophy, relative central adiposity, insulin resistance, and serum lipid abnormalities. We report 3 cases of HIV-1 infected patients who experienced symptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor indinavir. The mechanism behind this observation may be similar to that of previously reported protease inhibitor–associated fat redistribution, but instead involving the adipose tissue of discrete uncommon benign tumors. (J Am Acad Dermatol 2000;42:129-31.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Roy Colven, MD, 325 9th Ave, University of Washington-Harborview Medical Center, Department of Medicine-Division of Dermatology, Seattle, WA 98104. |
|
0190-9622/2000/$12.00 + 0 16/54/101896 |
Vol 42 - N° 1P1
P. 129-131 - janvier 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?